af is a stooge and i've learned long ago to ignore the clown. any new biotech investor would be wise to do the same.
had i listened to him, i would have never been long on either provenge and belviq efficacy and approval. at best his advice is like that of a monkey throwing darts; at worse, his advice is full of lies and half truth.
I don't think as poorly of Feuerstein as you do. I like that the reports he makes on various companies and enjoyed his reporting from ASCO via twitter. He gives background and some basics. Having said that, I sure as hell don't listen his predictions but he was on target with his ANTA prediction. The comments AF made about SNTA were pretty trivial,but he did make one mistake as he wrote the recently departed new Head of R&D was at SNTA for 3 months when he had only been there about 6 weeks.